Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deere & Company (DE) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Deere & CompanyTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Deere & Company vs DENTSPLY SIRONA Inc — how do they compare? Deere & Company trades at $616.53 (market cap $164.47B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.32B). The key difference: Deere & Company is far larger — about 70.9× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals.

DEXRAY
Market Cap
$164.47B$2.32B
Sector
IndustrialsHealth
52-Week High
$662.49$14.68
52-Week Low
$439.11$9.64
Enterprise Value
$219.29B$4.40B
Dividend Yield
1.06%5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deere & Company

Deere & Company (DE) trades at $620.83, up 0.97% for the day, with a bullish technical outlook supported by moving averages and recent earnings beats. Revenue declined to $44.67B in 2025, but net income margins remain healthy at 10.33%. The stock is near its pivot point of $620, with support at $613 and resistance at $628. Analyst consensus is a Moderate Buy with a $676.08 price target, reflecting optimism despite cyclical headwinds in agricultural equipment demand.

The outlook is cautiously positive, driven by consistent earnings outperformance and strong institutional holdings, but investors face risks from revenue volatility and high debt levels. The stock offers value if agricultural recovery materializes, but macroeconomic sensitivity warrants monitoring.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $12.12, down 7.97% in 24 hours, with a bearish technical signal and support near $12. The company reported Q2 2026 EPS of $0.52, beating expectations, but revenue declined 4.1% year-over-year. Financials show negative net income margins and ROE, though gross margins remain solid at 49.52%. Recent news highlights institutional stake increases and strategic partnerships, such as the expanded Medline Sinclair relationship in Canada.

The outlook is cautious due to persistent revenue declines and profitability challenges, offset by cost-cutting efforts and digital dentistry growth. Risks include weak European demand and high debt levels, while analyst consensus is Hold with a $11.50 price target, indicating limited near-term upside amid turnaround execution uncertainties.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Deere & Company

Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.

Read more on DE

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY